Skip to main content
. 2023 Jan 20;28(3):1039. doi: 10.3390/molecules28031039

Figure 3.

Figure 3

Baicalein modulates cell cycle regulatory proteins in G2/M phase via the ATM/CHK2/CDC25C signaling axis in ovarian cancer cells. (A) SKOV-3 and TOV-21G cells were treated with 50–200 μM baicalein for 48 h. (B) SKOV-3 cells were treated with 100 μM baicalein for 12–72 h. Immunoblotting showed the effect of baicalein on the protein levels of phospho-CHK2 and phospho-CDC25C, as well as the protein levels of CHK2, CDC25C, CDK1 and cyclin B1. β-actin was used as a loading control.